Abstract-Collagen types I and III, coded by COL1A1/COL1A2 and COL3A1 genes, are the major fibrillar collagens produced by fibroblasts, including cardiac fibroblasts of the adult heart. Characteristic for different cardiomyopathies is a remodeling process associated with an upregulation of collagen synthesis, which leads to fibrosis. We report identification of three mRNA-binding proteins, heterogeneous nuclear ribonucleoprotein (hnRNP) A1, E1, and K, as positive effectors of collagen synthesis acting at the post-transcriptional level by interaction with the 3Ј-untranslated regions (3Ј-UTRs) of COL1A1, 1A2, and 3A1 mRNAs. In vitro, binding experiments (electromobility shift assay and UV cross-linking) reveal significant differences in binding to CU-and AU-rich binding motifs. Reporter gene cell transfection experiments and RNA stability assays show that hnRNPs A1, E1, and K stimulate collagen expression by stabilizing mRNAs. Collagen synthesis is activated via the angiotensin II type 1 (AT 1 ) receptor. We demonstrate that transforming growth factor-␤1, a major product of stimulated AT 1 receptor, does not activate solely collagen synthesis but synergistically the synthesis of hnRNP A1, E1, and K as well. Thus, post-transcriptional control of collagen synthesis at the mRNA level may substantially be caused by alteration of the expression of RNA-binding proteins. The pathophysiological impact of this finding was demonstrated by screening the expression of hnRNP E1 and K in cardiovascular diseases. In the heart muscle of patients experiencing aortic stenosis, ischemic cardiomyopathy, or dilatative cardiomyopathy, a significant increase in the expression of hnRNP E1, A1, and K was found between 1.5-and 6.5-fold relative to controls. eposition of collagen fibers in the myocardial interstitium is a landmark for the remodeling process seen in a variety of cardiovascular diseases of quite different etiology, such as ischemic heart disease, cardiac hypertrophy, arterial hypertension, or the infarcted heart.
D
eposition of collagen fibers in the myocardial interstitium is a landmark for the remodeling process seen in a variety of cardiovascular diseases of quite different etiology, such as ischemic heart disease, cardiac hypertrophy, arterial hypertension, or the infarcted heart.
In the failing heart, several humoral, autocrine, and paracrine systems are activated and have been identified as potentially important mediators of collagen synthesis 1,2 and degradation by collagenases (metalloproteinases). 3 Many studies suggest that fibrosis is linked to an activation of the local renin-angiotensin system. 4, 5 It is known that angiotensin II (Ang II) directly stimulates collagen synthesis via Ang II type 1 (AT 1 ) receptors. Ang II is an inducer of transforming growth factor-␤1 (TGF-␤1) or the local aldosteron system, both positive effectors of collagen synthesis. 6, 7 Collagen types I and III (Col I and Col III) are the major fibrillar collagens produced by fibroblasts, including cardiofibroblasts in the adult heart. 8 The triple-helical collagen molecules are assembled by independently coded ␣1(I), ␣2(I), and ␣1(III) chains. Expression of the collagen genes (COL1A1, COL1A2, and COL3A1) is regulated at the transcriptional and post-transcriptional levels. Much is known about the complex transcription regulation of the collagen genes 9 and post-translational modification 10 ; however, less is known about post-transcriptional processes focusing on mRNA stability and translation. From studies in hepatic fibrosis, the importance of mRNA-specific posttranscriptional control in collagen synthesis was suggested. 11, 12 Molecular targets for these processes are 5Ј-untranslated regions (5Ј-UTRs) and 3Ј-UTRs of the collagen mRNAs interacting with RNA-binding regulative proteins. [12] [13] [14] Stem-loop structures in the 5Ј-UTR of all three mRNAs are involved in function of COL1A1, COL1A2, and COL3A1 mRNAs. 12 Whether common 3Ј-UTR-mediated principles also play a role in coordinate expression is unknown. For COL1A1 3Ј-UTR, a CU-rich element binding ␣CP (synonyms CP1, PCBP, heterogeneous nuclear ribonucleoprotein [hnRNP] E1) has been described that is respon-sible for mRNA stabilization. 13, 15, 16 Moreover, CU-rich elements involved in mRNA stabilization and translational control have been found in several mRNAs such as those coding for the globins, 17, 18 15 -lipoxygenase, 19, 20 poliovirus, 21 erythropoietin, 22 tyrosine hydroxylase, 23 folate receptor, 24 androgen receptor, 25 or renin. 26 In this study, we describe the identification of three RNA-binding proteins, hnRNP A1, E1, and K, interacting differently with 3Ј-UTRs of collagen 1A1, 1A2, and 3A1 mRNAs and investigate their role in coordinate expression of collagen I and III genes. Furthermore, data of patients with cardiac diseases are shown proving that fibrotic alteration of the myocardium is associated with an upregulation of the expression of collagen mRNA-stabilizing proteins.
Materials and Methods

Plasmids
3Ј-UTR transcription templates were generated by polymerase chain reaction (PCR) from human genomic DNA and cloned into the pCRII-TOPO vector (Invitrogen) or in pGL3 promoter (Promega). The 283-nt 3Ј-UTR1 collagen 1A1 mRNA sequence was amplified by PCR with primers 5Ј-ACTCCCTCCATCCCAACCT-3Ј and 5Ј-ACCAAGCTTCCTTTTTTAAAAAC-3Ј; the 312-nt 3Ј-UTR1 collagen 1A2 mRNA sequence with primers 5Ј-ATGAACTCAAT-CTAAATTA-3Ј and 5Ј-GCAAATGTTTATGGTTTTTATT-3Ј; and the 284-nt 3Ј-UTR1 collagen 3A1 mRNA sequence with primers 5Ј-ACCAAACTCTATCTGAA-3Ј and 5Ј-GTTATCAAAAGA-GTGTTGAAGTTT-3Ј. pGS5-E1, pGS5-A1, and pGS5-K were gifts from A. Ostareck-Lederer (Heidelberg). Expression cloning and affinity chromatography of hnRNP E1 and K have been described previously. 27 
Cell Culture
Human cardiac fibroblasts were isolated from explanted, end-stage failing adult human hearts, as described previously. 28 The resulting cell culture consisted almost exclusively of fibroblasts (96% to 98%). Primary fibroblast or HT1080 cells were cultured in DMEM using standard techniques.
Protein Extracts
HT1080 cells were resuspended in lysis buffer containing 10 mmol/L Tris, pH 7.5, 140 mmol/L NaCl, 1 mmol/L EDTA, 25% glycerol, 0.1% sodium dodecyl sulfate, 0.5% Nonidet P-40, 0.1 mmol/L dithiothreitol, and the "complete mini" protease inhibitor cocktail (Roche). S100 extracts were prepared as described previously. 26 
RNA Preparation and RT-PCR
Total RNA of cardiac fibroblast was isolated by the guanidine thiocyanate method following the manufacturer protocol (RNAzol; Biozol). Total RNA was treated with RNase-free DNase I using a standard protocol. The purity of the RNA was controlled by the A 260 /A 280 quotient. The integrity of the purified RNA was controlled by gel analysis. First-strand cDNA was synthesized in a final volume of 25 L containing first-strand buffer, 500 ng human cardiac fibroblast RNA, 600 ng random hexamer primer (Gibco), and Superscript reverse transcriptase (20 U/g RNA; Gibco). The mRNA levels for collagen I and III, hnRNP E1, hnRNP A1, hnRNP K, and the reference gene GAPDH (primer data available in an online supplement, available at http://circres.ahajournals.org) were determined by using "hot start" real-time PCR procedure with SYBR green that was validated with respect to the reproducibility and linearity within the measuring range. PCR was performed in duplicate with the Taqman (ABI 7000; Perkin-Elmer).
To correct for potential variances between samples in mRNA extraction and RT efficiency, the mRNA content of collagen I and III, hnRNP E1, hnRNP A1, and hnRNP K was related to the mRNA content of the stable expressed reference gene GAPDH from the same aliquot.
In Vitro Transcription, Electromobility Shift Assay, UV Cross-Linking, Blotting Methods, and Matrix-Assisted Laser Desorption IonizationTime-of-Flight-Mass Spectrometry
In vitro transcription, electromobility shift assay (EMSA), UV cross-linking, Northern blotting and matrix-assisted laser desorption ionization-time-of-flight-mass spectrometry (MALDI-TOF-MS) of affinity-purified RNA-binding proteins were performed as described previously. 26 For each experiment, 10 000 cpm (EMSA) or 100 000 cpm (UV cross-linking) 32 P-labeled transcript and 70 g HT1080 cytoplasmic extract was used. For Western blotting, the membranes were probed with anti-hnRNP E1, anti-hnRNP A1 antibody (a gift from G. Dreyfuss, University of Pennsylvania, Philadelphia), or collagen I antibody (DPC Biermann). Primary antibodies were used at 1:25000 (hnRNP E1), 1:1000 (hnRNP A1), or 1:2000 (collagen) in Tris-buffered saline Tween 20 (TBS-T) with 5% Chemiblocker overnight at 4°C. Immunoblots were incubated with horseradish peroxidase-conjugated antibody in TBS-T to visualize the immunoreactive bands with an enhanced chemiluminescence system (Amersham Pharmacia).
Transient Transfection and Luciferase Assay
HT1080 cells were grown to 80% confluence before transfection with 25 ng pGL3promoter collagen-3Ј-UTR constructs and different amounts of the eukaryotic expression plasmid coding for the hnRNP A1, E1, or K proteins using FuGENE 6 transfection reagent (Roche). Cells were cotransfected simultaneously with 0.5 g pSV-␤-galactosidase (␤-gal; Promega) as a transfection control. The transfected cells were fed complete growth medium for 48 hours and lysed in reporter lysis buffer (Promega). Luciferase assays were performed in a Berthold Lumat LB9501 luminometer. ␤-Gal activity was assayed as described in the protocol of the manufacturer (␤-gal enzyme assay system; Promega). Reporter gene activities were normalized to cotransfected controls.
TGF-␤ Stimulation
Cardiac fibroblasts were grown until 90% to 95% confluence. Before treatment, they were serum-deprived for 48 hours. TGF-␤1 (Calbiochem) was used in a range at 10 ng/mL (triplicates from each fibroblast preparation). In control experiments, cells received equivalent amounts of vehicle (1% BSA/4 mmol/L HCl). Cells were grown under these conditions for 6 and 12 hours.
Data Analysis
All reported values are meanϮSEM. Statistical analysis was performed using Student t test, with a P value of Ͻ0.05 regarded as significant.
Patients
Left ventricular myocardial samples from 18 patients with aortic stenosis (AS), 26 patients with heart failure attributable to dilatative cardiomyopathy (DCM), 6 patients with ischemic cardiomyopathy (ICM), and 20 control subjects were analyzed (patient data available in the online supplement). Small tissue samples from patients with AS were obtained by biopsy of the left ventricular septum at elective aortic valve replacement surgery. Tissue samples from patients with DCM or ICM were obtained as left ventricular septum biopsies at cardiac catheterization or at orthotopic heart transplantation. The control group was composed of donor hearts that were not used for logistic reasons. They had normal systolic cardiac function; cardiac history was absent, and postmortem histology was normal. Written informed consent was obtained from all patients. Experimental protocols were accepted by the local ethical committee. The investigation conforms with the principles outlined in the declaration of Helsinki.
Results
Interaction of HT1080 Cytosolic Proteins With Collagen 3-UTRs
To investigate the influence of mRNA-binding proteins on coordinate expression of the collagen genes, the 3Ј-UTRs of the mRNAs coding for the human collagen ␣1(I), ␣2(I), and ␣1(III) chains were cloned into the expression vector TOPO to allow in vitro transcription ( Figure 1 ). The three collagen type I and III genes are transcribed into more than one mRNA. They differ in the length of their 3Ј-UTRs by use of alternative polyadenylation signals. 29 -31 For our study, those three collagen I and III mRNAs were chosen ending with the first of the alternative poly-A signals. These transcripts represent abundant collagen mRNAs in fibroblasts when probed by Northern blotting. The sequences of the 3Ј-UTRs, including putative binding sites for RNA-binding proteins, are schematically depicted in Figure 1 .
To examine the ability of the collagen mRNA 3Ј-UTRs to interact with potential regulatory proteins, EMSAs were performed. To this purpose, 32 P-labeled transcripts were incubated with HT1080 cytosolic proteins, and the generation of mRNP complexes was analyzed. All three transcripts formed stable mRNP complexes (Figure 2 ). For identification of regulatory proteins potentially involved in turnover of collagen mRNAs, we also probed for candidate RNA-binding proteins hnRNP E1 and hnRNP K. hnRNP E1 was shown previously to bind to a CU-rich 3Ј-UTR element of COL1A1 mRNA, thereby stabilizing the mRNA. 13 hnRNP K, another K-domain protein, could be also a good candidate because of a similar oligo-C binding preference. 32 To this end, binding of recombinant hnRNP E1 and K to all three transcripts was examined (Figure 2) . The 3Ј-UTR transcripts of COL1A1 and COL1A2 bound hnRNP E1 and K. However, COL3A1 3Ј-UTR interacted only with hnRNP K but not with E1.
Identification of hnRNPs A1, E1, and K as Trans-Factors Binding to Collagen 3-UTRs
For more detailed information about the nature of the bound HT1080 cytosolic protein, UV cross-linking experiments were used. Labeled protein patterns of relatively low complexity were obtained ( Figure 3A, lanes 2 through 4) . These were compared with the cross-linking properties of recombinant E1 and K ( Figure 3A, lanes 5 through 10) . Identical electrophoretic migration of two dominant Ϸ39-kDa and 66-kDa bands (COL1A1, lane 1) strongly indicated that hnRNP E1 and K were the main cytosolic binding partners interacting with 3Ј-UTR of COL1A1 mRNA. This finding was verified by immunological techniques: antibodies against E1 and K immobilized on Sepharose beads recognized cross-linked E1 and K in cytosolic extracts (data not shown). The cross-linking pattern of COL1A2 and COL3A1 3Ј-UTR transcripts was consistent with the gel shift experiments: both bound hnRNP K, although with lower efficiency, in particular COL3A1. hnRNP E1 also interacted with COL1A2 but did not bind to COL3A1.
In contrast to COL1A1, the COL1A2 and COL3A1 transcripts bound a few additional polypeptides: COL1A2, a main band of Ϸ79 kDa, and COL3A1, three of Ϸ35, 62, and 85 kDa. To verify the hnRNPs E1 and K data and to search for the identity of the other cross-linked polypeptides, an RNA affinity chromatography approach was applied and coupled with MALDI-TOF-MS for their identification as described previously. 26 Apart from the verification of hnRNP E1 (39 kDa) and K (66 kDa), two additional collagen mRNAbinding proteins were identified: P85 as the Zn-finger protein ZNF224, 33 P62 as a proteolytic fragment of hnRNP K, and P35 as hnRNP A1 ( Figure 3B ). The 79-kDa band gave no unambiguous MALDI-TOF-MS spectra.
Functional Influence of hnRNPs A1, E1, and K on Collagen Expression
According to our results, A1 and A2 chains of COLI seem to be regulated in a similar way. Therefore, we decided to concentrate on the differences between type I and type III chains, studying COL1A1 mRNA as representative for type I collagen. To investigate the influence of hnRNP proteins A1, E1, and K, which have a well-documented impact on mRNA metabolism and function, we performed reporter gene assays. Because of the poor data on ZNF224, which is primarily known as a transcription factor, it was omitted from our analysis. Hybrid plasmids were constructed carrying the luciferase reporter gene as coding and the 3Ј-UTRs of three human collagen genes as regulatory unit, as described in Figure 1 . HT1080 cells were transfected with the LucCOL-3Ј-UTR constructs and cotransfected with plasmids expressing human hnRNP proteins E1, K, or A1. The concentrationdependent transfection was optimized previously to overexpress hnRNP proteins Ն3-fold over their endogenous levels in HT1080 cells using Western blots (data not shown). The results of the cotransfection experiments are summarized in Figure 4 . The expression of reporter luciferase plasmid carrying the COL1A1-3Ј-UTR (LucCOL1A1) was stimulated 2-to 5-fold when cotransfected with hnRNP expression plasmids E1, K, or A1 (E1 2ϫ, K 2ϫ, and A1 5ϫ) in a concentration-dependent manner (Figure 4 , lanes 1 through Figure 4 . A, Influence of hnRNP A1, E1, or K on the expression of luciferase-COL3Ј-UTR reporter genes. A total of 10 5 HT1080 cells were transiently transfected with 0.025 g of Luc reporter construct containing the COL1A1 3Ј-UTR (lanes 1 through 9) or COL3A1 3Ј-UTR (lanes 10 through 18; Figure 1 ) and 0.5 g of pSV-␤-gal as a transfection control. In addition, 0.025 g (lanes 1 and 10) , 0.25 g (lanes 2 and 11), or 2.5 g (lanes 3 and 12) of pSG5-E1; 0.025 g (lanes 4 and 13), 0.25 g (lanes 5 and 14) , or 2.5 g (lanes 6 and 15) of pSG5-K; 0.025 g (lanes 7 and 16), 0.25 g (lanes 8 and 17) , or 2.5 g (lanes 9 and 18) of pSG5-A1 expression plasmids were cotransfected. Luciferase activity was determined luminometrically. Transfections with the Luc plasmid alone were set at 100%. Data (meansϮSD) represent the results of three independent experiments (data are shown in online supplement; S3). P values were 0.05 and 0.01 vs control conditions. *PϽ0.01; *PϽ0.05. B, Influence of hnRN proteins E1 and K on stability of LucCOL3Ј-UTR transcripts in vitro. 32 P-labeled LucCOL3Ј-UTR capped and polyadenylated transcripts were generated and subjected to in vitro degradation as described previously. 26 For each experiment, 2⅐10 4 cpm transcript was incubated with 20 g HT1080 cytoplasm as RNase source, and with recombinant E1 or K (for COL IA1 20 ng E1/K, each; and for COL IIIA1 20 ng E1 or K). Aliquots were removed after the times indicated and analyzed by agarose electrophoresis, blotting onto membranes, and autoradiography. Stability of transcripts was determined by quantifying autoradiographic signals using the program Molecular Analyst and graphical estimation of half-life times. 9). The same experiment was repeated with LucCOL3A1-3Ј-UTR. hnRNP K and A1 stimulated the expression Ϸ4-and 6-fold, whereas E1 had no influence (lanes 10 through 15). To investigate the capability of hnRNPs E1 and K to act as RNA stabilizers in vitro, RNase degradation assays 26 were performed using luciferase transcripts carrying collagen 3Ј-UTRs and recombinant hnRNP E1 and K ( Figure 4B) . The experiments show that the addition of E1 and K resulted in an Ϸ4-fold increase in in vitro half-life time of LucCOL1A1 reporter transcript (7.5 versus 30 minutes). The stability of LucCOL3A1 transcript increased Ϸ2-fold in the presence of K (27.5 versus 50 minutes), whereas E1 had no effect. This demonstrates that collagen mRNA 3Ј-UTRs can mediate mRNA stabilization via the action of different independently acting RNA-binding proteins.
Synergistic Induction of Collagens and hnRNPs A1, E1, and K by TGF-␤1
TGF-␤1 is a known effector in the signaling pathway of collagen expression and the synthesis of other connecting tissue proteins involved in fibrotic processes. 5, 34 We asked whether the induction of collagens I and III by TGF-␤1 is likewise accompanied by an upregulation of collagen mRNAbinding proteins. The well-known effect of TGF-␤1 on the induction of the connective tissue growth factor (CTGF) served as a positive control. 35 Collagens I and III as well as CTGF accumulated under the action of TGF-␤1 for 6 to 12 hours by a factor of Ϸ2. Under the same conditions, the level of the mRNAs of all three hnRNP proteins A1, E1, and K increased significantly between 40% and 70% compared with the controls without TGF-␤1 ( Figure 5A ). Immunological quantification of RNA-binding proteins for which antibodies were available revealed that hnRNPs A1 and E1 were upregulated by factors 5.2 and 3.4, respectively. As controls, COLI and GAPDH were also quantified. As expected, COLI was induced Ϸ4.3-fold, whereas GAPDH remained constant. This demonstrated that COL mRNA-binding proteins are synergistically induced like extracellular matrix proteins and may contribute significantly to the observed posttranscriptional upregulation of collagen synthesis.
Selected Cardiomyopathies Are Characterized by an Increased Expression of COL mRNA-Binding Proteins
We were able to show in vitro and in vivo that COL mRNA-binding proteins contribute to the process of upregulation of collagen synthesis. Thus, their increase could be of pathophysiological significance for the mechanism of fibrosis generation. To test this hypothesis, we analyzed heart biopsy specimens of patients experiencing different heart diseases, such as AS, DCM, or ICM, for the mRNA level of COL mRNA-binding proteins hnRNP E1, A1, and K by real-time Figure 6 ). Indeed, particularly in AS, a striking increase in the E1, A1, and K mRNA level by the factors 3.5, 6.5, and 4.5 was observed. In our previous studies, samples of a comparable patient cohort with AS, partially overlapping with that analyzed in this study, were characterized by an increased collagen expression. 4 In ICM, the E1/K expression was elevated Ϸ2-fold. hnRNP E1, A1, and K were not significantly altered in DCM.
PCR (
Discussion
We present molecular and clinical data that hnRNP proteins binding to collagen mRNAs are involved in the mechanism of induction of collagen synthesis and in development of cardiac fibrosis. Several lines of evidence indicate that expression of the genes coding for the two collagens mainly elevated in organ fibrosis, collagens type I and III, is controlled predominantly post-transcriptionally at the mRNA level. 13 Stem-loop structures in the 5Ј-UTR of the three COL1A1, 1A2, and 3A1 mRNAs are involved in translational control. 12 Moreover, the 3Ј-UTR of at least one member of the family, COL1A1 mRNA, has been shown to be a target for mRNA-binding protein ␣CP (hnRNP E), which is involved in mRNA stabilization. 11 The coordinated expression of type I and III collagens let us presume further common post-transcriptional mechanisms targeting at the mRNA 3Ј-UTR level.
An inspection of the sequences after consensus motifs for RNA-binding proteins predicted hnRNP E1 binding to COL1A1 and COL1A2, hnRNP A1 binding to COL3A1, and hnRNP K binding to all three 3Ј-UTRs (Figure 1) . Experimentally, we can show that indeed, all three behaved accordingly and fulfilled this prediction (Figures 2 and 3) . The consensus motifs for hnRNP E1 and K binding have been examined thoroughly using the SELEX method. 32 That revealed, briefly for K, a motif centering in the sequence UCCCA/UA/U, and for E1, a cluster of 2 to 3 U of C 3 to 4 in a CU-rich environment of Ϸ20 to 30 nucleotides. We previously defined the so-called "differentiation control element" a CU-rich, repetitive structure in lipoxygenase and other mRNAs binding hnRNP E1 and K 19, 27 with a consensus C 4 A/GC 3 UCUUC 4 AAG. 35, 36 Other work 32, 37 and ours suggests that the binding regions for K and E1 may be fairly variable. But all have in common that hnRNP K requires at least a C 3 to 4 core flanked by A or U and is G-poor, and that hnRNP E1 needs a more extended CU-rich binding region containing at least two C 3 to 4 units. 20 The experimental results obtained with the collagen 3Ј-UTRs confirm our experiences: all three, COL1A1, 1A2, and 3A1 3Ј-UTRs, contain hnRNP K-like consensus motifs and do actually bind it. COL1A1 contains a classical CU-rich hnRNP E1-binding site as demonstrated previously. 15 According to our results, COL1A2 has the same feature: it is also able to bind hnRNP E1, although not COL3A1, which lacks a more extended CU-rich region. Thus, E1 is a common factor associated to COL1A1 and 1A2 mRNA 3Ј-UTR, which could facilitate coordinate expression of the two subunits of type I collagen. The same is true for hnRNP K with respect to a coordinate expression of collagens I and III.
The situation with hnRNP A1 is more ambiguous. The binding preference of A1 seems to be not very distinctly marked. 38 Because of its more general RNA-binding properties, it is often called a "core" hnRNP protein. Nevertheless, there are reports showing that hnRNP A1 prefers AU-rich regions of the type AUUUA, which otherwise bind preferentially AU-rich element binding proteins such as AUF1 (hnRNP D) or HuR. 39, 40 Despite its low-sequence preference, in our cross-linking assays, A1 bound only to COL3A1, which indeed contains two AUUUA motifs (Figure 1 ). This is in a certain way incompatible with our A1 transfection experiments (Figure 4 ). The expression of the LucCOL3Ј-UTR reporter gene constructs is considerably stimulated when cotransfected with an A1 expression plasmid. This argues in favor of an active interaction of hnRNP A1 with all three UTRs. However, it cannot be excluded that in vitro cross-linking conditions are not fully compatible with in vivo transfection conditions. Another explanation may be that A1 did not interact directly with the RNA but could be coordinated by protein/protein interactions during mRNP assembly, which is not reflected by RNA/protein cross-linking patterns.
Functionally of importance is the fact that those hnRNP proteins, which bind to COL I and III mRNAs, are described as positive effectors of mRNA stability. In our hands, the half-life time of luciferase transcript carrying COL IA1 3Ј-UTR increased in vitro by recombinant hnRNP E1 and K, and that carrying COL IIIA1 3Ј-UTR by K, although not by E1 ( Figure 4B ). This concept of differential action on IA1/IIIA1 3Ј-UTRs was strengthened further by the negative result of the LucCOL3A1 E1 cotransfection experiment: hnRNP E1, which did not bind to COL3A1 3Ј-UTR ( Figure   Figure 6 . Expression of the genes coding for hnRNP E1 and K in hearts from patients experiencing different cardiac diseases. Total RNA was extracted from patient biopsy specimens of the left ventricle and mRNAs of hnRNPs A1, E1, and K were quantified by real-time RT-PCR. Values were normalized to GAPDH mRNA concentrations. Controls nϭ20; AS nϭ18; DCMs nϭ26; ICMs nϭ6. **PϽ0.001; *PϽ0.05.
2, gel shift), also failed consequently to stimulate Luc reporter gene expression (Figure 4, lanes 10 and 11) . The stimulation rates for E1 and K action in the cotransfection experiments are in good accordance with the TGF-␤1 stimulation results ( Figure 5 ). TGF-␤1 is a well-known mediator of the signaling pathway governing collagen expression via the AT 1 receptor. 4, 7 We show that hnRNP A1, E1, and K expression is synergistically upregulated in the same range as the collagens and CTGF by TGF-␤1. Thus, RNA-binding hnRNP proteins are important cytoplasmic control molecules defining the fibrotic status of a tissue. A pathophysiological relevance of this finding was confirmed by screening patients experiencing different heart diseases associated with fibrosis. They were analyzed for their potential to express hnRNP proteins E1, A1, and K in the left ventricle. hnRNP E1 and K mRNA was significantly increased in the myocardium of patients with AS or ICM, as well as hnRNP A1 mRNA, which was also found to be most increased in AS, and thus elevated that hnRNPs may play a role in collagen content regulation in AS.
There are several reports underlining the importance of 3Ј-UTR-mediated mRNA stability in cardiovascular pathophysiology. 40 Scenarios can be envisaged in which the altered level of mRNA stabilizing/destabilizing proteins or mutations in the 3Ј-UTR-binding motifs of mRNAs of cardiovascular important proteins may constitute molecular events on the way of development of different cardiovascular diseases. The expression of important signaling proteins in the heart as ␤ 1 -adrenergic receptor or AT 1 /AT 2 receptors was shown to be modulated by alterations of the level of RNA-binding proteins such as AUF1, HuR, or hnRNP A1 in the context of heart failure. [41] [42] [43] hnRNP E1 (␣-CP1, PCBP1) is known to be involved in post-transcriptional response to hypoxia. It is a regulatory protein that binds to a hypoxia-inducible CU-rich binding site in erythropoietin or tyrosine hydroxylase mRNA. This has been shown to be of pathophysiological significance. 22, 23 In conclusion, the data from the present study suggest that mRNA-binding proteins hnRNP A1, E1, and K substantially participate in the coordinative upregulation of collagen I and III synthesis in cardiac fibrosis. This is caused by an increase in their expression via the AT 1 receptor way in which TGF-␤1 plays a critical role. Mechanistically, the RNA-binding proteins may act as stabilizers of the collagen mRNAs, effectively promoting collagen synthesis in this way.
